Results 181 to 190 of about 910,182 (402)
ANÆSTHETIC DEATHS DUE TO REGURGITATION OR VOMITING [PDF]
, 1951 H. J. V. Morton, W.D. Wylie
openalex +1 more source
Research Progress of CeO2‐Containing Catalysts in Catalytic Oxidation of CO
Carbon and Hydrogen, EarlyView.The latest progress of CeO2‐based catalysts for low‐temperature catalytic oxidation of CO is summarized. In this paper, we focus on the synthesis method, doping of active metal components, regulation of active sites, and regulation of optimal exposed crystal planes, and solve the challenges and future prospects in this field.
Junjie Li +3 more
wiley +1 more source
The Effect of Ginger Biscuit on Nausea and Vomiting in Early Pregnancy
Acta Medica Iranica, 2009 Nausea and vomiting of pregnancy (NVP) are often alleviated by eating dried biscuits or foods. Natural products such as ginger have been suggested as herbal remedies for its treatment.
Zahra Basirat +3 more
doaj
Determining predictors of underlying etiology and clinical deterioration in patients with physiologic instability in the emergency department [PDF]
, 2013 Thesis (M.A.)--Boston UniversityShock is a critical state defined by inadequate oxygen delivery to tissues. It is well known in the critical care community that early diagnosis and treatment of shock are crucial to improving patient outcomes. However, in
Day, Danielle E.
core +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract Endogenous oxytocin plays an important role in lactation, but its effectiveness as an exogenous galactagogue has been modest due to dose‐limiting side effects related to off‐target effects at the vasopressin V2 receptor. Merotocin (FE 202767) is a short‐acting peptidic oxytocin receptor agonist with the potential to aid mothers experiencing ...
Yu Bagger +4 more
wiley +1 more source
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
New England Journal of Medicine, 2016 R. Navari +9 more
semanticscholar +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract Zanubrutinib is a next‐generation Bruton tyrosine kinase inhibitor approved for treating B‐cell malignancies. Two phase 1 studies evaluated a new 160‐mg zanubrutinib tablet versus 80‐mg capsules. In study BGB‐3111‐115 (n = 43), a randomized 3‐period crossover trial, relative bioavailability and food effects were assessed.
Bilal Tariq +5 more
wiley +1 more source
Acta Médica Costarricense, 2010 Objetivo: Evaluar y caracterizar el abordaje farmacoterapéutico antiemético en el periodo postoperatorio en pacientes adultos sometidos a cirugía en el Hospital Clínica Bíblica (hospital privado en Costa Rica).
Natalia Apuy-Roldán +3 more
doaj